Responsiveness and construct validity of EPIC-26, AQoL-6D and SF-6D following treatment in prostate cancer

PURPOSE: To assess construct validity and responsiveness of the Expanded Prostate Cancer Index Composite Instrument (EPIC-26) relative to the Short-Form Six-Dimension (SF-6D) and Assessment of Quality of Life 6-Dimension (AQoL-6D) in patients following treatment for prostate cancer. METHODS: Retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Bulamu, Norma B., Mpundu-Kaambwa, Christine, O’Callaghan, Michael, Kaambwa, Billingsley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067207/
https://www.ncbi.nlm.nih.gov/pubmed/37005587
http://dx.doi.org/10.1186/s12885-023-10732-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067207/
https://www.ncbi.nlm.nih.gov/pubmed/37005587
http://dx.doi.org/10.1186/s12885-023-10732-6

Ejemplares similares